Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program

BACKGROUND: Although adjuvant cancer treatments increase cure rates, they may induce clonal selection and tumor resistance. Information still lacks as whether (neo)adjuvant anti-HER2 treatments impact the patterns of recurrence and outcomes of HER2-positive (HER2+) metastatic breast cancer (MBC). We...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Du, Fanny, Carton, Matthieu, Bachelot, Thomas, Saghatchian, Mahasti, Pistilli, Barbara, Brain, Etienne, Loirat, Delphine, Vanlemmens, Laurence, Vermeulin, Thomas, Emile, George, Gonçalves, Anthony, Ung, Mony, Robert, Marie, Jaffre, Anne, Desmoulins, Isabelle, Jouannaud, Christelle, Uwer, Lionel, Marc Ferrero, Jean, Mouret-Reynier, Marie-Ange, Jacot, William, Chevrot, Michaël, Delaloge, Suzette, Diéras, Véronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Breast Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546827/
https://www.ncbi.nlm.nih.gov/pubmed/37589218
http://dx.doi.org/10.1093/oncolo/oyad137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546827/
https://www.ncbi.nlm.nih.gov/pubmed/37589218
http://dx.doi.org/10.1093/oncolo/oyad137

Ejemplares similares